Press Releases

Now Available! Gestalt Diagnostics announces availability of their Education Module. This robust module is a continuation of the modules and applications built upon their Digital Pathology Platform, PathFlow®. PathFlow historically focused on the specific needs of the clinical pathology lab and workflow for digital pathology. The addition of the Education Module increases the scope, interoperability […]

Gestalt Diagnostics is happy to be named among the 25+5 Top Emerging Tech Companies with an Inland Northwest presence.  30 companies were chosen for their growth potential, their status as privately held, and the fact they all were launched fewer than 12 years ago. All 30 companies are either headquartered or have a substantial presence in

Gestalt Diagnostics and MindPeak today announced their strategic relationship on the development of an integrated workflow for pathologists to instantaneously send regions of interest to MindPeak. MindPeak’s Image Analysis services for digital images support ER, PR and Ki-67. The companies are providing a faster, more streamlined diagnostic process for breast cancer patients. “By integrating with

Gestalt Diagnostics and Flagship Biosciences today announced their collaboration in the development of an integrated workflow for pathologists to access Flagship’s Image Analysis services for digital images to support PD-L1 testing.The companies are providing a more efficient diagnostic process by engaging in a shared service to add Flagship’s computational services to Gestalt’s digital pathology solution,

Gestalt Diagnostics’ today announced their development of an artificial intelligence algorithm that identifies and routes more critical cases first to the appropriate pathologist based upon a pathologist’s specialty. “Digital pathology is the key to faster, more accurate patient diagnosis and today we have taken that even further with our development of an image analysis protocol

Gestalt Diagnostics has created an Advisory Board led by their Medical Director, Dr.David Hoak. The board consists of Pathologists who have extensive backgrounds in leading edge technology, regulatory expertise and a focus on emerging technologies such as digital pathology.  Advisory board members include: Dr. Bruce Beckwith, pathologist and Chairman of Pathology at North Shore Medical Center

Gestalt Diagnostics announced today that it has finalized the acquisition of laboratory integration services company Peak Medical. This strategic acquisition expands Gestalt’s digital pathology integration services division and provides key industry expertise inhealthcare connectivity services in addition to integration and support for LIS solutions.  Peak, and its employees, will be fully integrated into Gestalt and

Gestalt Diagnostics announces that it has been selected as the digital pathology solution of choice by PathologyWatch. PathologyWatch, remote pathology experts providing local laboratories the opportunity to partner with expert pathologists for interpretation of their specimens, has chosen Gestalt’s PathFlow™ as the core solution for their digital pathology business.  Gestalt Diagnostics announces that it has been selected

Gestalt Diagnostics has added well known Healthcare industry veteran, Dr.Hoak to serve as their Medical Director. He will be responsible for leading Gestalt’s distinguished Advisory Board of pathologists, for providing oversight and active management on development initiatives as they relate to compliance and patient safety. Dr. Hoak is also publishing a blog entitled, Pathology Consultant, which will focus

MedTech Outlook publishes an annual listing of the Top 10 companies that are at the forefront of solving oncology challenges through technology. “We are excited to be recognized in this annual listing,” says Gestalt’s COO & CSO, Lisa-Jean Clifford. “Our goal is to provide digital pathology solutions that transform healthcare – from testing through treatment.